vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.

IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $143.8M, roughly 1.9× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 4.8%, a 19.4% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs 2.9%). IPG PHOTONICS CORP produced more free cash flow last quarter ($10.9M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs 4.4%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

CNS vs IPGP — Head-to-Head

Bigger by revenue
IPGP
IPGP
1.9× larger
IPGP
$274.5M
$143.8M
CNS
Growing faster (revenue YoY)
IPGP
IPGP
+14.3% gap
IPGP
17.1%
2.9%
CNS
Higher net margin
CNS
CNS
19.4% more per $
CNS
24.3%
4.8%
IPGP
More free cash flow
IPGP
IPGP
$137.3M more FCF
IPGP
$10.9M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
4.4%
IPGP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
IPGP
IPGP
Revenue
$143.8M
$274.5M
Net Profit
$34.9M
$13.3M
Gross Margin
36.1%
Operating Margin
28.0%
1.2%
Net Margin
24.3%
4.8%
Revenue YoY
2.9%
17.1%
Net Profit YoY
-23.9%
69.8%
EPS (diluted)
$0.67
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
IPGP
IPGP
Q4 25
$143.8M
$274.5M
Q3 25
$141.7M
$250.8M
Q2 25
$136.1M
$250.7M
Q1 25
$134.5M
$227.8M
Q4 24
$139.8M
$234.3M
Q3 24
$133.2M
$233.1M
Q2 24
$121.7M
$257.6M
Q1 24
$122.7M
$252.0M
Net Profit
CNS
CNS
IPGP
IPGP
Q4 25
$34.9M
$13.3M
Q3 25
$41.7M
$7.5M
Q2 25
$36.8M
$6.6M
Q1 25
$39.8M
$3.8M
Q4 24
$45.8M
$7.8M
Q3 24
$39.7M
$-233.6M
Q2 24
$31.8M
$20.2M
Q1 24
$34.0M
$24.1M
Gross Margin
CNS
CNS
IPGP
IPGP
Q4 25
36.1%
Q3 25
39.5%
Q2 25
37.3%
Q1 25
39.4%
Q4 24
38.6%
Q3 24
23.2%
Q2 24
37.3%
Q1 24
38.7%
Operating Margin
CNS
CNS
IPGP
IPGP
Q4 25
28.0%
1.2%
Q3 25
34.5%
3.1%
Q2 25
31.8%
0.0%
Q1 25
33.6%
0.8%
Q4 24
35.3%
6.0%
Q3 24
33.7%
-108.7%
Q2 24
31.5%
4.7%
Q1 24
32.8%
7.6%
Net Margin
CNS
CNS
IPGP
IPGP
Q4 25
24.3%
4.8%
Q3 25
29.4%
3.0%
Q2 25
27.1%
2.6%
Q1 25
29.6%
1.6%
Q4 24
32.8%
3.3%
Q3 24
29.8%
-100.2%
Q2 24
26.1%
7.8%
Q1 24
27.7%
9.6%
EPS (diluted)
CNS
CNS
IPGP
IPGP
Q4 25
$0.67
$0.30
Q3 25
$0.81
$0.18
Q2 25
$0.72
$0.16
Q1 25
$0.77
$0.09
Q4 24
$0.89
$0.27
Q3 24
$0.77
$-5.33
Q2 24
$0.63
$0.45
Q1 24
$0.68
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
IPGP
IPGP
Cash + ST InvestmentsLiquidity on hand
$145.5M
$839.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
$2.1B
Total Assets
$876.7M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
IPGP
IPGP
Q4 25
$145.5M
$839.3M
Q3 25
$98.1M
$870.4M
Q2 25
$95.4M
$899.6M
Q1 25
$65.2M
$926.9M
Q4 24
$183.0M
$930.2M
Q3 24
$106.5M
$1.0B
Q2 24
$122.0M
$1.1B
Q1 24
$99.5M
$1.1B
Stockholders' Equity
CNS
CNS
IPGP
IPGP
Q4 25
$562.0M
$2.1B
Q3 25
$550.3M
$2.1B
Q2 25
$528.5M
$2.1B
Q1 25
$507.7M
$2.1B
Q4 24
$511.7M
$2.0B
Q3 24
$491.0M
$2.1B
Q2 24
$463.2M
$2.3B
Q1 24
$378.9M
$2.3B
Total Assets
CNS
CNS
IPGP
IPGP
Q4 25
$876.7M
$2.4B
Q3 25
$801.6M
$2.4B
Q2 25
$751.0M
$2.4B
Q1 25
$834.9M
$2.3B
Q4 24
$812.4M
$2.3B
Q3 24
$727.8M
$2.4B
Q2 24
$784.1M
$2.5B
Q1 24
$680.7M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
IPGP
IPGP
Operating Cash FlowLast quarter
$-120.4M
$28.8M
Free Cash FlowOCF − Capex
$-126.4M
$10.9M
FCF MarginFCF / Revenue
-87.9%
4.0%
Capex IntensityCapex / Revenue
4.2%
6.5%
Cash ConversionOCF / Net Profit
-3.45×
2.17×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
IPGP
IPGP
Q4 25
$-120.4M
$28.8M
Q3 25
$55.1M
$35.3M
Q2 25
$-67.6M
$-2.2M
Q1 25
$-108.9M
$13.4M
Q4 24
$96.7M
$73.8M
Q3 24
$25.6M
$66.1M
Q2 24
$31.4M
$53.5M
Q1 24
$4.9M
$54.6M
Free Cash Flow
CNS
CNS
IPGP
IPGP
Q4 25
$-126.4M
$10.9M
Q3 25
$52.6M
$14.6M
Q2 25
$-69.8M
$-17.6M
Q1 25
$-110.0M
$-11.4M
Q4 24
$85.0M
$50.6M
Q3 24
$24.2M
$43.0M
Q2 24
$27.1M
$29.2M
Q1 24
$537.0K
$26.5M
FCF Margin
CNS
CNS
IPGP
IPGP
Q4 25
-87.9%
4.0%
Q3 25
37.1%
5.8%
Q2 25
-51.3%
-7.0%
Q1 25
-81.8%
-5.0%
Q4 24
60.8%
21.6%
Q3 24
18.2%
18.4%
Q2 24
22.3%
11.3%
Q1 24
0.4%
10.5%
Capex Intensity
CNS
CNS
IPGP
IPGP
Q4 25
4.2%
6.5%
Q3 25
1.8%
8.3%
Q2 25
1.6%
6.1%
Q1 25
0.8%
10.9%
Q4 24
8.3%
9.9%
Q3 24
1.1%
9.9%
Q2 24
3.5%
9.4%
Q1 24
3.5%
11.1%
Cash Conversion
CNS
CNS
IPGP
IPGP
Q4 25
-3.45×
2.17×
Q3 25
1.32×
4.73×
Q2 25
-1.84×
-0.34×
Q1 25
-2.74×
3.58×
Q4 24
2.11×
9.44×
Q3 24
0.65×
Q2 24
0.99×
2.65×
Q1 24
0.14×
2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

Related Comparisons